Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology

This editorial celebrates the launch of BMC Pharmacology and Toxicology within the BMC series of journals published by BioMed Central. The scope of the journal is interdisciplinary encompassing toxicology, experimental and clinical pharmacology including clinical trials. In this editorial we discuss...

Descripción completa

Detalles Bibliográficos
Autores principales: Moylan, Elizabeth C, Morrey, Christopher, Appleford-Cook, Joanne M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506264/
https://www.ncbi.nlm.nih.gov/pubmed/22946996
http://dx.doi.org/10.1186/2050-6511-13-1
_version_ 1782250876227813376
author Moylan, Elizabeth C
Morrey, Christopher
Appleford-Cook, Joanne M
author_facet Moylan, Elizabeth C
Morrey, Christopher
Appleford-Cook, Joanne M
author_sort Moylan, Elizabeth C
collection PubMed
description This editorial celebrates the launch of BMC Pharmacology and Toxicology within the BMC series of journals published by BioMed Central. The scope of the journal is interdisciplinary encompassing toxicology, experimental and clinical pharmacology including clinical trials. In this editorial we discuss the origins of this new journal and the ethos and policies under which it will operate.
format Online
Article
Text
id pubmed-3506264
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35062642012-11-29 Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology Moylan, Elizabeth C Morrey, Christopher Appleford-Cook, Joanne M BMC Pharmacol Toxicol Editorial This editorial celebrates the launch of BMC Pharmacology and Toxicology within the BMC series of journals published by BioMed Central. The scope of the journal is interdisciplinary encompassing toxicology, experimental and clinical pharmacology including clinical trials. In this editorial we discuss the origins of this new journal and the ethos and policies under which it will operate. BioMed Central 2012-08-13 /pmc/articles/PMC3506264/ /pubmed/22946996 http://dx.doi.org/10.1186/2050-6511-13-1 Text en Copyright ©2012 Moylan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Moylan, Elizabeth C
Morrey, Christopher
Appleford-Cook, Joanne M
Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
title Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
title_full Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
title_fullStr Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
title_full_unstemmed Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
title_short Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
title_sort only connect: the merger of bmc pharmacology and bmc clinical pharmacology
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506264/
https://www.ncbi.nlm.nih.gov/pubmed/22946996
http://dx.doi.org/10.1186/2050-6511-13-1
work_keys_str_mv AT moylanelizabethc onlyconnectthemergerofbmcpharmacologyandbmcclinicalpharmacology
AT morreychristopher onlyconnectthemergerofbmcpharmacologyandbmcclinicalpharmacology
AT applefordcookjoannem onlyconnectthemergerofbmcpharmacologyandbmcclinicalpharmacology

Ejemplares similares